| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P | 24% | $18.5M | 10.3M | BVF PARTNERS L P/IL | Nov 20, 2025 | |||
| ARK Investment Management LLC | 4.7% | $2M | 2M | ARK Investment Management LLC | Dec 31, 2024 | |||
| MPM BioVentures 2014, L.P. | 4.6% | -10% | $1.94M | -$208K | 1.94M | -9.69% | ANSBERT GADICKE | Jan 31, 2025 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Change | Price | Investors |
|---|---|---|---|---|---|
| 2025 Q3 | 27.3M | $48M | -$586K | $1.76 | 44 |
| 2025 Q2 | 27.8M | $38.6M | -$1.38M | $1.39 | 49 |
| 2025 Q1 | 29.5M | $29.1M | -$1.27M | $0.99 | 49 |
| 2024 Q4 | 30.6M | $40.1M | -$3.25M | $1.31 | 53 |
| 2024 Q3 | 32.4M | $111M | -$4.68M | $3.44 | 56 |
| 2024 Q2 | 33.8M | $112M | -$7.68M | $3.30 | 60 |
| 2024 Q1 | 35.5M | $167M | -$6.15M | $4.71 | 70 |
| 2023 Q4 | 39.6K | $289K | +$171K | $7.30 | 1 |
| 2023 Q3 | 36.2M | $438M | +$5.74M | $12.08 | 73 |
| 2023 Q2 | 35.8M | $379M | +$27.7M | $10.58 | 76 |
| 2023 Q1 | 33.2M | $327M | -$3.87M | $9.84 | 76 |
| 2022 Q4 | 33.4M | $492M | +$9.67M | $14.71 | 78 |
| 2022 Q3 | 32.6M | $396M | -$27.7M | $12.13 | 64 |
| 2022 Q2 | 30.3M | $424M | +$10.3M | $13.99 | 66 |
| 2022 Q1 | 32.5M | $463M | -$16.8M | $14.24 | 58 |
| 2021 Q4 | 32.2M | $679M | +$74.3M | $21.09 | 61 |
| 2021 Q3 | 27M | $708M | +$10.2M | $26.24 | 66 |
| 2021 Q2 | 26.4M | $824M | +$15.2M | $31.18 | 60 |
| 2021 Q1 | 26M | $798M | +$23.9M | $30.69 | 63 |
| 2020 Q4 | 24.2M | $830M | +$31.4M | $34.30 | 58 |
| 2020 Q3 | 23.9M | $735M | +$26M | $30.77 | 36 |
| 2020 Q2 | 20.1M | $624M | +$624M | $31.02 | 46 |
| 2020 Q1 | 100 | $3K | $0 | $30.00 | 1 |
| 2019 Q4 | 100 | $3K | $0 | $30.00 | 1 |
| 2019 Q3 | 100 | $3K | $0 | $30.00 | 1 |
| 2019 Q2 | 100 | $3K | $0 | $30.00 | 1 |
| 2019 Q1 | 100 | $3K | $0 | $30.00 | 1 |